NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that it will host an investor reception on Sunday, June 1, 2008 at 6:00 p.m. CDT in Chicago.
